{"id":"W4377969339","doi":"10.1016/j.kint.2023.05.009","title":"Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","year":2023,"lang":"en","type":"review","venue":"Kidney International","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; Seven Oaks General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Akebia Therapeutics; Astellas Pharma; Torii Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Fresenius Medical Care North America; AstraZeneca; GlaxoSmithKline; Amgen; U.S. Department of Veterans Affairs","keywords":"Medicine; Kidney disease; Anemia; Intensive care medicine; Guideline; Disease; Adverse effect; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004258239,0.001119645,0.004279416,0.002528402,0.000325704,0.002003641,0.001412151,0.002031503,0.004218339],"category_scores_gemma":[0.005784679,0.0003686866,0.00315403,0.003176511,0.0004620965,0.001837369,0.00127356,0.003837262,0.000881914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001594885,"about_ca_system_score_gemma":0.00523372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004193647,"about_ca_topic_score_gemma":0.01093535,"domain_scores_codex":[0.9993184,0.0002044967,0.0001403183,0.00007139285,0.0002105182,0.00005498533],"domain_scores_gemma":[0.9970244,0.00199592,0.0002698286,0.00003460178,0.0005524165,0.0001228892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005083513,0.00008771896,0.0002142563,0.1279912,0.001851306,0.00008108639,0.00007910001,0.0002933647,0.0003583016,0.003534107,0.08777858,0.7772226],"study_design_scores_gemma":[0.0006058671,0.000281684,0.002161436,0.1769704,0.009431706,0.0003143426,0.0001386992,0.0001849255,0.0002017956,0.003119885,0.8065366,0.00005254432],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002938556,0.9986972,0.00002550901,0.0007664125,0.0002883313,0.000006383178,0.00002781715,0.00000251059,0.0001563126],"genre_scores_gemma":[0.0003260548,0.998187,0.0001374181,0.001024901,0.0001870883,0.00001104588,0.00003236743,0.000001146639,0.00009291621],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004279416,"threshold_uncertainty_score":0.02252001,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04415841328740496,"score_gpt":0.3536618694551403,"score_spread":0.3095034561677354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}